Scimago Lab
powered by Scopus
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST


Medical Science Monitor Basic Research


eISSN: 1643-3750

Get your full text copy in PDF

4G/5G polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene in subjects with node-negative and node-positive breast cancer

Beata Smolarz, Janusz Błasiak, Jacek Pytel, Hanna Romanowicz-Makowska, Marek Zadrożny

Med Sci Monit 1999; 5(5): BR833-837

ID: 503262

PAI-1 is a serine protease inhibitor involved in the degradation of the extracellular matrix during malignant tumor invasion and its high level in breast cancer is associated with a poor prognosis for patients. It is supposed that 4G/5G insertion/deletion polymorphism, with a sequence of either four guanosines or five guanosines, in the promoter of the PAI-1 gene may play a functional role in PAI-1 synthesis, affecting the level of circulating PAI-1. To investigate whether the progression of breast cancer may be related to a particular genotype, 4G/5G polymorphism in patients with node-negative (n=17) and node-positive (n=20) breast cancer was studied. The subjects were 44 to 82 years old, with a median age of 59 years. Formalin-fixed, paraffin-embedded material from ductal breast carcinoma was used. The tumors' diameter was about 20 mm and they were classified of II, II°, III or III°grade. The 4G/5G polymorphism of PAI-1 gene was determined by the allele specific polymerase chain reaction (ASO-PCR). The genotype distribution differed significantly between node-negative and node-positive groups. The 4G allele was observed more frequently in node-negative patients (0.74) compared with 5G allele (0.26), whereas in subjects with node-positive the frequency 4G and 5G allele were 0.48 and 0.52, respectively. Different distribution of the 4G/5G genotypes in patients indicate that this genetic variation itself may be a risk factor for breast cancer invasive phenotype, so the association of the 4G/5G polymorphism with breast cancer progression is worth further studying.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree